Osaka, Japan

Akiyoshi Tani

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiyoshi Tani. Retrieved from https://idiyas.com/inventor/akiyoshi-tani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akiyoshi Tani: Innovator in MAP Kinase Research

Introduction

Akiyoshi Tani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of MAP kinases. His work has implications for understanding various cellular processes and diseases.

Latest Patents

Akiyoshi Tani holds a patent for a "Method for assaying ERK2 map kinase." This innovative method utilizes a monoclonal antibody generated by immunizing a mammal with human MAP kinase ERK1, along with a polyclonal antibody generated by immunizing an animal with the phosphorylation region of the MAP kinase sequence. This technique allows for the detection and assay of various MAP kinase species, including ERK2.

Career Highlights

Akiyoshi Tani is associated with Takeda Chemical Industries, Inc., where he has been instrumental in advancing research in the field of MAP kinases. His expertise and innovative approaches have contributed to the company's reputation as a leader in pharmaceutical research and development.

Collaborations

Akiyoshi Tani has worked alongside Yuzo Ichimori, collaborating on various projects that enhance the understanding of MAP kinases and their applications in medicine.

Conclusion

Akiyoshi Tani's contributions to the field of biochemistry, particularly through his patent on MAP kinase assay methods, highlight his role as an influential inventor. His work continues to impact research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…